WSGR logoWSGR logo
Aaron B. Gordon
Associate
Corporate
Boston

D617-598-7839

Download vCard
Open PDF

Aaron B. Gordon is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where he is a part of the firm’s corporate practice.

During law school, Aaron was a summer associate and law clerk in Wilson Sonsini’s Boston office, where he assisted in representation of early-stage life sciences companies.

Experience

Aaron B. Gordon is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where he is a part of the firm’s corporate practice.

During law school, Aaron was a summer associate and law clerk in Wilson Sonsini’s Boston office, where he assisted in representation of early-stage life sciences companies.

Focus Areas
Recent Insights
Client Highlights
Wilson Sonsini Advises GC Therapeutics on $65 Million Series A
On September 19, 2024, GC Therapeutics (GCTx), a biopharmaceutical company created to scale and unlock the next generation of cell therapy-based medicines, launched and announced the successful completion of a $65 million Series A financing led by Cormorant Asset Management with participation from Mubadala Capital, Andreessen Horowitz (a16z) Bio + Health, Medical Excellence Capital, Cercano Management, and Pear VC, bringing the total capital raised by GCTx to $75 million. Wilson Sonsini Goodrich & Rosati advised GC Therapeutics on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Amber Bio on $26 Million Seed Financing
On August 3, 2023, Amber Bio, a biotechnology company pioneering multi-kilobase gene editing platforms to reach previously undruggable diseases, announced $26 million in seed funding co-led by Playground Global and Andreessen Horowitz Bio + Health with participation from Eli Lilly, RDF (Retinal Degeneration Fund), Hummingbird Ventures, and Pillar VC. Wilson Sonsini Goodrich & Rosati advised Amber Bio on the transaction.
Learn More
View All
WSGR logo
Copyright © 2024 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.